Severity of Pain and Sleep Problems during Kratom (Mitragyna speciosa Korth.) Cessation among Regular Kratom Users

References

• Adkins, J. E., E. W. Boyer, and C. R. McCurdy. 2011. Mitragyna speciosa: A psychoactive tree from Southeast Asia with opioid activity. Current Topics in Medicinal Chemistry 11:1165–75. doi:10.2174/156802611795371305.
   PubMed Web of Science ®Google Scholar
• Ahmad, K., and Z. Aziz. 2012. Mitragyna speciosa use in the northern states of Malaysia: A cross-sectional study. Journal of Ethnopharmacoly 141:446–50. doi:10.1016/j.jep.2012.03.009.
   PubMed Web of Science ®Google Scholar
• Aisyaturridha, A., and A. J. Nizar. 2006. Validation of Malay brief pain inventory questionnaire to measure cancer pain. Journal Pain Symptom Manage 31:13–21. doi:10.1016/j.jpainsymman.2005.06.011.
   PubMed Web of Science ®Google Scholar
• Anwar, M., R. Law, and J. Schier. 2016. Notes from the field: Kratom (Mitragyna speciosa) exposures reported to poison centers: United States, 2010– 2015. CDC 65 (29):748–49.
   Google Scholar
• Assanangkornchai, S., A. Muekthong, N. Sam-Angsri, and U. Pattanasattayawong. 2007. The use of mitragynine species (“krathom”), an addictive plant, in Thailand. Substance Use and Misuse 42:2145–57. doi:10.1080/10826080701205869.
   PubMed Web of Science ®Google Scholar
• Buyasse, D. J., C. F. Reynolds, T. H. Monk, S. R. Berman, and D. J. Kupfer. 1989. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Research 28 (2):193–213. doi:10.1016/0165-1781(89)90047-4.
   PubMed Web of Science ®Google Scholar
• Carpenter, J. S., and M. A. Andrykowski. 1998. Psychometric evaluation of the Pittsburgh sleep quality index. Journal of Psychosomatic Research 45 (1):5–12. doi:10.1016/S0022-3999(97)00298-5.
   PubMed Web of Science ®Google Scholar
• Cinosi, E., G. Martinotti, P. Simonato, D. Singh, Z. Demetrovics, A. Roman-Urrestarazu, F. S. Bersani, B. Vicknasingam, G. Piazzon, J. H. Li, W. J. Yu, M. Kapitany-Foveny, J. Farkas, M. D. Giannantonio, and O. Corazza. 2015. Following “the roots” of kratom (Mitragyna speciosa): The evolution of an enhancer from a traditional use to increase work and productivity in Southeast Asia to a recreational psychoactive drug in Western countries. BioMed Research International 1–11.
   PubMed Web of Science ®Google Scholar
• Cleeland, C. S., and K. M. Ryan. 1994. Pain assessment: Global use of the brief pain inventory. Annals of the Academy of Medicine, Singapore 23:129–38.
   PubMedGoogle Scholar
• Dhingra, L., D. C. Perlman, C. Masson, J. Chen, C. Mcknight, A. E. Jordan, T. Wasser, R. K. Portenoy, and M. D. Cheatle. 2015. Longitudinal analysis of pain and illicit drug use behaviors in outpatients on methadone maintenance. Drug Alcohol Depend 149:285–89. doi:10.1016/j.drugalcdep.2015.02.007.
   PubMed Web of Science ®Google Scholar
• Domingo, O., G. Roider, A. Stover, M. Graw, F. Musshoff, H. Sachs, and W. Bicker. 2017. Mitragynine concentrations in two fatalities. Forensic Science International 271:e1–7. doi:10.1016/j.forsciint.2016.12.020.
   PubMed Web of Science ®Google Scholar
• Forrester, M. B. 2013. Kratom exposures reported to Texas poison centers. Journal of Addictive Diseases 32:396–400. doi:10.1080/10550887.2013.854153.
   PubMed Web of Science ®Google Scholar
• Galbis-Reig, D. 2016. A case report of kratom addiction and withdrawal. WMJ: Official Publication of the State Medical Society of Wisconsin 115:49–52.
   PubMedGoogle Scholar
• Griffin, O. H., and M. E. Webb. 2017. The scheduling of kratom and selective use of data. Journal Psychoactive Drugs 176:63–70. doi:10.1080/02791072.2017.1371363.
   Web of Science ®Google Scholar
• Grundmann, O. 2017. Patterns of kratom use and health impact in the U.S.: Results from an online survey. Drug and Alcohol Dependence 176:63–70. doi:10.1016/j.drugalcdep.2017.03.007.
   PubMed Web of Science ®Google Scholar
• Hassan, Z., M. Muzaimi, V. Navaratnam, N. H. M. Yusoff, F. W. Suhaimi, R. Vadivelu, B. K. Vicknasingam, D. Amato, S. V. Horsten, N. I. W. Ismail, N. Jayabalan, A. I. Hazim, S. M. Mansor, and C. P. Muller. 2013. From kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction. Neuroscience and Biobehavioral Reviews 37:138–51. doi:10.1016/j.neubiorev.2012.11.012.
   PubMed Web of Science ®Google Scholar
• Holler, J. M., Vorce, S. P., McDonough-Bender, P. C., Jr., J. M., Solomon, C. J., and Levine, B. 2011. A Drug Toxicity Death Involving Propylhexedrine and Mitragynine. Journal of Analytical Toxicology. 35:54–59.
   PubMed Web of Science ®Google Scholar
• Kapp, F. G., H. H. Maurer, V. Auwarter, M. Winkelmann, and M. Hermanns-Clausen. 2011. Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa). Journal Medica Toxicogical 7:227–231. doi:10.1007/s13181-011-0155-5.
   Google Scholar
• Karinen, R., J. T. Fosen, S. Rodge, and V. Vindenes. 2014. An accidental poisoning with mitragynine. Forensic Science International 245:e29–e32. doi:10.1016/j.forsciint.2014.10.025.
   PubMed Web of Science ®Google Scholar
• Kronstrand, R., M. Roman, G. Thelander, and A. Eriksson. 2011. Unintentional fatal intoxications with Mitragynine and O-desmethyltramadol from the herbal blend krypton. Journal of Analytical Toxicology 35:242–47. doi:10.1093/anatox/35.4.242.
   PubMed Web of Science ®Google Scholar
• Kruegel, A. C., M. M. Gassaway, A. Kapoor, A. Varadi, S. Majumdar, M. Filizola, J. A. Javitch, and D. Sames. 2016. Synthetic and receptor signalling exploration of the Mitragyna alkaloids: Mitragynine as an atypical molecular framework for opioid receptor modulators. Journal of the American Chemical Society 138:6754–64. doi:10.1021/jacs.6b00360.
   PubMed Web of Science ®Google Scholar
• Kruegel, A. C., and O. Grundmann. 2017. The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology 1 (13):1–13..
   Google Scholar
• Lee, C. T. 1957. Addiction to Mitragyna speciosa. Proceedings of the Alumni Association, University Malaya, Kuala Lumpur, Malaysia, 10, 322–24.
   Google Scholar
• Lydecker, A. G., A. Sharma, C. R. McCurdy, B. A. Avery, K. M. Babu, and E. W. Boyer. 2016. Suspected adulteration of commercial kratom products with 7-hydroxymitragynine. Journal Medica Toxicogical 12:341–49. doi:10.1007/s13181-016-0588-y.
   Web of Science ®Google Scholar
• McIntyre, I. M., A. Trochta, S. Stolberg, and S. C. Campman. 2015. Mitragynine “kratom” related fatality: A case report with postmortem concentrations. Journal of Analytical Toxicology 39:152–55. doi:10.1093/jat/bku137.
   PubMed Web of Science ®Google Scholar
• McWhirter, L., and S. Morris. 2010. A case report of inpatient detoxification after kratom (Mitragyna speciosa) dependence. European Addiction Research 16:229–31. doi:10.1159/000320288.
   PubMed Web of Science ®Google Scholar
• Neerman, M. F., R. E. Frost, and J. Deking. 2013. A drug fatality involving kratom. Journal of Forensic Sciences 58:S1. doi:10.1111/1556-4029.12009.
   Web of Science ®Google Scholar
• Nelsen, J. L., J. Lapoint, M. J. Hodgman, and K. M. Aldous. 2010. Seizure and coma following kratom (Mitragynine speciosa Korth.) exposure. Journal Medica Toxicogical 6:424–26. doi:10.1007/s13181-010-0079-5.
   Google Scholar
• Peles, E., S. Schreiber, J. Gordon, and M. Adelson. 2006. Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend 82:103–10. doi:10.1016/j.drugalcdep.2005.08.011.
   PubMed Web of Science ®Google Scholar
• Pinney Associates. 2016. Assessment of kratom under the CSA eight factors and scheduling recommendation. http://www.pinneyassociates.com/wp-content/uploads/2017/07/Kratom-8-Factor-by-PinneyAssoc-11.28.16.pdf
   Google Scholar
• Poquet, N., and C. Lin. 2016. The Brief Pain Inventory (BPI). Journal of Physiotherapy 62:52. doi:10.1016/j.jphys.2015.07.001.
   PubMed Web of Science ®Google Scholar
• Prozialeck, W. C. 2016. Update on the pharmacology and legal status of Kratom. The Journal of the American Osteopathic Association 116 (12):802–09. doi:10.7556/jaoa.2016.156.
   PubMed Web of Science ®Google Scholar
• Prozialeck, W. C., J. K. Jivan, and S. V. Andurkar. 2012. Pharmacology of kratom: An emerging botanical agent with stimulant, analgesic and opioid-like effects. The Journal of the American Osteopathic Association 112 (12):792–99.
   PubMedGoogle Scholar
• Rosenblum, A., H. Joseph, C. Fong, S. Kipnis, C. Cleland, and R. K. Portenoy. 2003. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 289 (18):2370–78. doi:10.1001/jama.289.18.2370.
   PubMed Web of Science ®Google Scholar
• Saingam, D., A. Assanangkornchai, A. F. Geater, and S. Lerkiatbundit. 2014. Validation of krathom (Mitragyna speciosa Korth.) dependence scale (KDS): A dependence screen for internationally emerging psychoactive substance. Substance Abuse 35:276–83. doi:10.1080/08897077.2014.924464.
   PubMed Web of Science ®Google Scholar
• Saingam, D., A. Assanangkornchai, A. F. Geater, and S. Lerkiatbundit. 2016. Factor analytical investigation of krathom (Mitragyna speciosa Korth.) withdrawal syndrome in Thailand. Journal of Psychoactive Drugs 48:76–85.
   PubMed Web of Science ®Google Scholar
• Saingam, D., S. Assanangkornchai, A. F. Geater, and Q. Balthip. 2012. Pattern and consequences of krathom (Mitragyna speciosa Korth.) use among male villagers in southern Thailand: A qualitative study. The International Journal on Drug Policy 24 (4):351–58. doi:10.1016/j.drugpo.2012.09.004.
   PubMed Web of Science ®Google Scholar
• Singh, D., C. P. Muller, and B. Vicknasingam. 2014. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug and Alcohol Dependence 139:132–37. doi:10.1016/j.drugalcdep.2014.03.017.
   PubMed Web of Science ®Google Scholar
• Singh, D., C. P. Muller, B. K. Vicknasingam, and S. M. Mansor. 2015. Social Functioning of kratom (Mitragyna speciosa) users in Malaysia. Journal of Psychoactive Drugs 47 (2):125–31. doi:10.1080/02791072.2015.1012610.
   PubMed Web of Science ®Google Scholar
• Singh, D., S. Narayanan, and B. Vicknasingam. 2016. Traditional and non-traditional uses of Mitragynine (kratom): A survey of the literature. Brain Research Bulletin 126:41–46. doi:10.1016/j.brainresbull.2016.05.004.
   PubMed Web of Science ®Google Scholar
• Singh, D., S. Narayanan, B. Vicknasingam, O. Corazza, R. Santacroce, and A. Roman-Urrestarazu. 2017. Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia. Human Psychopharmacology Clinical Experiments e2582:1–6. doi:10.1002/hup.2582.
   Web of Science ®Google Scholar
• Smith, K. E., and T. Lawson. 2017. Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program. Drug and Alcohol Dependence 180:340–48. doi:10.1016/j.drugalcdep.2017.08.034.
   PubMed Web of Science ®Google Scholar
• Suwanlert, S. 1975. A study of kratom eaters in Thailand. Bulletin on Narcotics 27 (3):21–27.
   PubMedGoogle Scholar
• Swogger, M. T., E. Hart, F. Erowid, E. Erowid, N. Trabold, K. Yee, K. A. Parkhurst, B. M. Priddy, and Z. Walsh. 2015. Experiences of kratom users: A qualitative analysis. Journal Psychoactive Drugs 47 (5):360–67. doi:10.1080/02791072.2015.1096434.
   PubMed Web of Science ®Google Scholar
• Swogger, M. T., and Z. Walsh. 2018. Kratom use and mental health: A systematic review. Drug and Alcohol Dependence 183:134–40. doi:10.1016/j.drugalcdep.2017.10.012.
   PubMed Web of Science ®Google Scholar
• Tanguay, P. 2011. Kratom in Thailand: Decriminalisation and community control? Series on legislative reform of drug policies, vol. 13, International Drug Policy Consortium (IDPC). https://www.tni.org/files/download/kratom-briefing-dlr13.pdf.
   Google Scholar
• Varadi, A., G. F. Marrone, T. C. Palmer, A. Narayan, M. R. Szabo, V. L. Rouzic, and S. G. Grinnell. 2016. Mitragynine/corynanthedine pseudoindoxyls as opioid analgesics with mu agonism and delta antagonism, which do not recruit B-arrestin-2. Journal of Medicinal Chemistry 59:8381–97. doi:10.1021/acs.jmedchem.6b00748.
   PubMed Web of Science ®Google Scholar
• Vicknasingam, B., S. Narayanan, G. T. Beng, and S. M. Mansor. 2010. The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. International Journal of Drug Policy 21:283–88. doi:10.1016/j.drugpo.2009.12.003.
   PubMed Web of Science ®Google Scholar
• Warner, M. L., N. C. Kaufman, and O. Grundmann. 2015. The pharmacology and toxicology of kratom: From traditional herb to drug of abuse. International Journal of Legal Medicine 130:127–38. doi:10.1007/s00414-015-1279-y.
   PubMed Web of Science ®Google Scholar